(Q48177429)

English

What Are the Most Important Symptom Targets When Treating Advanced Cancer? A Survey of Providers in the National Comprehensive Cancer Network (NCCN)

scientific article published on January 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/14533442

What Are the Most Important Symptom Targets When Treating Advanced Cancer? A Survey of Providers in the National Comprehensive Cancer Network (NCCN) (English)

1 reference

10.1081/CNV-120022366

https://api.crossref.org/works/10.1081/CNV-120022366

19 March 2024

1 reference

10.1081/CNV-120022366

https://api.crossref.org/works/10.1081/CNV-120022366

19 March 2024

1

object named as

David Cella

1 reference

Europe PubMed Central

9 February 2018

author name string

Diane Paul

2

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/14533442

Susan Yount

3

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/14533442

Rodger Winn

4

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/14533442

Chih-Hung Chang

5

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/14533442

Donald Banik

6

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/14533442

Jane Weeks

7

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/14533442

language of work or name

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14533442

19 March 2024

publication date

1 January 2003

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/14533442

full work available at URL

http://www.tandfonline.com/doi/pdf/10.1081/CNV-120022366

1 reference

10.1081/CNV-120022366

https://api.crossref.org/works/10.1081/CNV-120022366

19 March 2024

Cancer Investigation

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/14533442

21

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/14533442

526-535

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/14533442

4

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/14533442

Measuring health-related quality of life

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022366

21 January 2018

The use of quality of life data in clinical practice

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022366

21 January 2018

Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes.

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022366

21 January 2018

Physicians' perspective on quality of life: an exploratory study of oncologists.

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022366

21 January 2018

Ratings of the importance of quality of life variables: therapeutic implications for patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022366

21 January 2018

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022366

21 January 2018

The Functional Assessment of Cancer Therapy scale: development and validation of the general measure

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022366

21 January 2018

Symptom prevalence, characteristics and distress in a cancer population.

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022366

21 January 2018

Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument.

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022366

21 January 2018

Reliability and validity of the functional assessment of cancer therapy-ovarian.

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022366

21 January 2018

Quality of life and functional status measures in patients with head and neck cancer

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022366

21 January 2018

Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument.

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022366

21 January 2018

Reliability and validity of the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) quality of life instrument

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022366

21 January 2018

RTOG's first quality of life study--RTOG 90-20: a phase II trial of external beam radiation with etanidazole for locally advanced prostate cancer.

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022366

21 January 2018

The Functional Assessment of Cancer Therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors.

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022366

21 January 2018

Symptom and quality of life survey of medical oncology patients at a veterans affairs medical center: a role for symptom assessment

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022366

21 January 2018

Palliative effect of chemotherapy: objective tumor response is associated with symptom improvement in patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022366

21 January 2018

The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress.

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022366

21 January 2018

Symptom assessment

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022366

21 January 2018

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022366

21 January 2018

Methodologic assessments of quality of life measures in clinical trials

1

1 reference

10.1081/CNV-120022366

https://api.crossref.org/works/10.1081/CNV-120022366

19 March 2024

Clinical Therapeutics

2

14

850

author name string

Coons S.J.

publication date

1992

1 reference

10.1081/CNV-120022366

https://api.crossref.org/works/10.1081/CNV-120022366

19 March 2024

Cancer Treatment Reports

4

69

1155

author name string

Johnson J.R.

publication date

1985

1 reference

10.1081/CNV-120022366

https://api.crossref.org/works/10.1081/CNV-120022366

19 March 2024

Barriers to the use of health status measures in clinical investigation, patient care, and policy research

6

1 reference

10.1081/CNV-120022366

https://api.crossref.org/works/10.1081/CNV-120022366

19 March 2024

Progress, problems and priorities in quality of life research

9

1 reference

10.1081/CNV-120022366

https://api.crossref.org/works/10.1081/CNV-120022366

19 March 2024

Science, language, intuition, and the many meanings of quality of life.

11

1 reference

10.1081/CNV-120022366

https://api.crossref.org/works/10.1081/CNV-120022366

19 March 2024

References for health-related quality-of-life claims in prescription drug advertisements

18

1 reference

10.1081/CNV-120022366

https://api.crossref.org/works/10.1081/CNV-120022366

19 March 2024

Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument.

26

1 reference

10.1081/CNV-120022366

https://api.crossref.org/works/10.1081/CNV-120022366

19 March 2024

Predictors and consequences of symptom reporting behaviors in colorectal cancer patients

35

1 reference

10.1081/CNV-120022366

https://api.crossref.org/works/10.1081/CNV-120022366

19 March 2024

Identifiers

10.1081/CNV-120022366

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/14533442

release_kmjpufblffc7bhz3bkxr3sxcp4

0 references

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/14533442

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48177429&oldid=2105699938"